
Event Description
Join us for the Seattle Myeloma Round Table at The Westin Bellevue Hotel on Saturday, October 14 from 9 am-3 pm PDT. Registration opens at 8:00 am.
Meeting Details
- Meeting date: Saturday, October 14, 2023
- Registration opens at 8:00 am, meeting begins at 9:00 am
- Location: Westin Bellevue Hotel (600 Bellevue Way NE, Bellevue, WA 98004, USA)
- Registration, parking, lunch and refreshments are free
- The meeting will be recorded and available to watch at a later time
- Nearest Airport: Seattle - Tacoma International Airport (SEA)
REGISTER TO WATCH THE RECORDING
If you can't make the meeting in person, please register to watch the recording. We will send an email out to all recording registrants about a week following the live meeting.
MAKE IT A WEEKEND:
If you are traveling to the meeting and would like to make a weekend of it while you are in Seattle, here are some suggestions:
- Three top hotels: Seattle Marriott Bellevue, Hilton Garden Inn Seattle Bellevue, Hyatt Regency Bellevue
- Three top restaurants: STK Steakhouse Bellevue, Seastar Restaurant & Raw Bar, The Pink Door
- Three top activities: Space Needle, Pike Place Market, Museum of History & Industry
Questions?
For questions about registration, contact us at +1-800-709 -1113 or support@healthtree.org.
For all other questions, contact Jenny at jenny@healthtree.org or 801-949-1034.
Schedule & Agenda
Registration and Breakfast starts at 8:00 AM PT

- Welcome
- Introduction and Meeting Logistics

- Transplant innovation and how it influenced today’s cellular therapies
- The path to CAR T development

- CAR T's evolution (dual CARs)
- New targets and new approaches in CAR T
- CAR T or bispecifics? What, when and how?

- Managing the unfamiliar: side effects in the age of new myeloma treatments
- Caregiver insights and watchful eyes
- Managing with or without a caregiver

- Bone health
- Optimizing care for outcomes and quality of life

Jenny – Introduction
Rahul Banerjee, MD, FACP – Extending Remissions for Newly Diagnosed Myeloma Patients / Using Digital Health to Improve Outcomes
- CD38 approaches in newly diagnosed patients or as maintenance
- Using digital health to improve outcomes
- Q&A
OR
Andrew Cowan, MD - The Single Front Door: Personalizing Therapy for Each Relapsed/Refractory Myeloma Patient
- Determining best treatments at diagnosis and relapse for each individual patient
- Coordinating care between academic and local centers
- Q&A
- Join the HealthTree Western Community Chapter
- Join HealthTree Cure Hub and accelerate Dr. Banerjee's research
- Get educated with HealthTree programs
Speakers & Moderators

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Dr Cowan is an assistant professor at UW and Fred Hutch in the division of medical oncology where he focuses on care and research of patients with multiple myeloma and AL amyloidosis. His primary interests lie in helping bring new therapies to patients in the clinic, and helping improve understanding of the global state of multiple myeloma through research collaborations with colleagues abroad.

Dr. Banerjee’s clinical interests are in multiple myeloma, AL amyloidosis, and CAR-T therapy. His research interests are in toxicity management, digital health, and the patient experience.

“A cancer diagnosis is often complicated, frightening, and confusing. I try to help my patients understand their disease and their treatment choices so that we can work towards the best possible outcomes together.” Dr. Silbermann is a physician-scientist with expertise in multiple myeloma and other plasma cell disorders. She has a particular interest in myeloma bone disease and a research program focused on maintaining and improving bone health in myeloma patients. Dr. Silbermann has two children and spends her free time exploring the Portland area with her family.

After graduating Cum Laude from Cornell University with a Bachelor of Science in Human Development, Dr. Kara Cicero volunteered with AmeriCorps. Faced with the reality of health-related inequities, she was motivated to pursue a career focused on minimizing health disparities. Accordingly, she attended Tulane University School of Medicine and obtained a Master of Public Health in Global Health Systems and Development, in addition to her Medical Degree. There, she was inducted into the Alpha Omega Alpha Honor Medical Society and was honored with the Harry and Rose Caplovitz Internal Medicine Award. She also received the Jack Ling Travel Award and Penny Jessop Travel Fund for teaching local healthcare workers in Malawi. Dr. Cicero returned to her home state of New York to complete residency in Internal Medicine at Columbia University, New York Presbyterian, and was inspired to pursue a career in oncology. She remained at Columbia for her clinical fellowship in Hematology and Medical Oncology, where she was granted multiple awards for her research in global oncology, including the American Association for Cancer Research Cancer Disparities Fellowship, the American Society of Clinical Oncology Young Investigator Award, and the Herbert Irving Comprehensive Cancer Center Trainee Associate Member Postdoctoral Pilot Award. Following training, Dr. Cicero was drawn to the Pacific Northwest’s active, outdoor culture, and more specifically, University of Washington’s collaborative environment of compassionate faculty. She joined the Myeloma program in the Division of Hematology, where she cares for those with multiple myeloma, amyloidosis, and other plasma cell disorders. She continues to be involved in research endeavors focused on health disparities, such as leading an international, multidisciplinary team on a project assessing the prevalence of MGUS in Eswatini (formerly Swaziland) to deepen the epidemiologic understanding of MGUS and multiple myeloma in an understudied population that is also most likely to be affected.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org
Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.
Thanks to our HealthTree Community for Multiple Myeloma Sponsors:






.svg_7bb6fd32-1b73-4ca9-9a2f-8fd6fc59d528.png?alt=media)